No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleonly females |
293145 |
2. Check conditionsNone |
293145 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
245 |
4. Check minimum number of eventsNone |
245 |
5. Include endpointsNone |
245 |
6. Filter based on genotype QC (FinnGen only) |
242 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Mucinous and mucinous cystic tumor, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of ovary, including Hilmo
- malignant neoplasm of female genital organs, including Hilmo
- Solid cancers, including Hilmo
- Malignant neoplasm, wide definition
- Malignant neoplasm, including Hilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 242 | 242 | - |
| Unadjusted period prevalence (%) | 0.09 | 0.09 | - |
| Median age at first event (years) | 54.44 | 54.44 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 245
- Matched controls
- 2450
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
+∞
287.6
216
*
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
54.9
154.1
93
27
H02AB02
ATC
dexamethasone; systemic
89.2
147.0
79
13
JEA00
NOMESCO Finland
Appendectomy
25.2
118.7
96
61
8470/3-C56.9
ICD-O-3
Mucinous cystadenocarcinoma, NOS, of ovary
+∞
114.9
101
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
32.7
106.7
74
32
128
Kela drug reimbursment
Cancers of female genital organs
+∞
96.4
86
*
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
25.2
92.6
71
39
WX302
NOMESCO Finland
Thoracal epidural anesthesy
37.5
92.3
60
21
8480/3-C56.9
ICD-O-3
Mucinous adenocarcinoma of ovary
+∞
85.5
77
*
A04AA01
ATC
ondansetron; systemic, rectal
26.4
83.7
62
31
JAL30
NOMESCO Finland
Omentectomy
168.3
79.6
80
7
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
+∞
78.4
71
*
JN4BD
NOMESCO Finland
Extensive body CT
21.2
73.5
60
37
LCD00
NOMESCO Finland
Hysterectomy
13.9
70.4
76
77
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
66.8
61
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
15.8
56.5
53
42
A03FA01
ATC
metoclopramide; systemic, rectal
7.6
55.4
115
254
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
50.8
47
*
B01AB10
ATC
tinzaparin; parenteral
7.7
43.0
74
131
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
43.0
40
*
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
41.9
39
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
8.6
41.7
62
93
121
Kela drug reimbursment
Severe hypofunction of sexual glands
16.7
40.8
36
25
JN4AD
NOMESCO Finland
Body CT examination
9.2
35.8
48
63
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
34.2
32
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
5.3
31.6
83
215
A04AA02
ATC
granisetron; systemic, transdermal
355.9
31.6
31
*
L03AA13
ATC
pegfilgrastim; parenteral
342.4
30.5
30
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
342.4
30.5
30
*
JAL00
NOMESCO Finland
Biopsy of peritoneum
70.5
27.7
31
5
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
4.2
27.0
146
640
B01AB05
ATC
enoxaparin; parenteral
4.1
27.0
129
519
130
Kela drug reimbursment
Malignant tumour
+∞
26.5
25
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
5.0
26.2
71
186
D39.11
ICD-10 Finland
Epithelial tumor of uncertain nature in the ovary
26.1
26.1
36
16
Z31.5
ICD-10 Finland
Genetic counselling
8.3
24.9
35
48
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
24.4
23
*
L03AA02
ATC
filgrastim; parenteral
+∞
23.3
22
*
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
+∞
23.3
22
*
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
+∞
22.2
21
*
Z51.5
ICD-10 Finland
Palliative care
8.4
21.7
30
40
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
21.1
20
*
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
228.6
20.9
21
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
20.1
19
*
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
20.4
19.6
29
16
A04AA03
ATC
tropisetron; systemic
205.0
18.8
19
*
115
Kela drug reimbursment
Breast cancer
+∞
17.9
17
*
R18
ICD-10 Finland
Ascites
26.4
17.7
24
10
HA1AA
NOMESCO Finland
X-ray mammography
6.2
17.5
32
58
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.5
17.1
47
122
A04AA55
ATC
palonosetron, combinations; systemic
+∞
16.9
16
*
JAH01
NOMESCO Finland
Laparoscopy
6.4
16.6
29
50
L02BG04
ATC
letrozole; oral
20.3
16.4
24
13
TPH07
NOMESCO Finland
Cathetrisation of artery
4.5
16.2
44
113
ZX120
NOMESCO Finland
Intravenous
6.0
15.9
30
56
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
15.8
15
*
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
6.1
15.7
29
53
X77
ICPC
Malignant neopl genital female other
+∞
14.7
14
*
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
+∞
14.7
14
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
159.1
14.6
15
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
11.1
14.4
27
27
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
79.7
13.7
15
*
JAL31
NOMESCO Finland
Laparoscopic omentectomy
+∞
13.7
13
*
8380/3-C56.9
ICD-O-3
Endometrioid adenocarcinoma, NOS, of ovary
+∞
13.7
13
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
13.7
13
*
1830A
ICD-9 Finland
Malignant neoplasm of ovary and other uterine adnexa, Ovary
+∞
13.7
13
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
13.7
13
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
19.6
13.6
20
11
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
12.6
12
*
C567, ,
ICD-10 Finland
+∞
12.6
12
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
12.6
12.1
21
18
D27.91
ICD-10 Finland
Benign epithelial tumor of the ovary (ovary)
13.5
11.9
20
16
N02AA05
ATC
oxycodone; systemic
3.1
11.7
59
228
WW500
NOMESCO Finland
Blood transfusion
14.6
11.7
19
14
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
11.5
11
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
11.5
11
*
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
125.7
11.5
12
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
45.5
11.0
13
*
WX402
NOMESCO Finland
General anaesthesia
2.8
10.9
67
288
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
3.1
10.9
53
200
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
62.8
10.7
12
*
L02BA01
ATC
tamoxifen; oral
+∞
10.5
10
*
L01BC06
ATC
capecitabine; oral
+∞
10.5
10
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
12.9
10.0
17
14
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
12.1
9.7
17
15
JAH00
NOMESCO Finland
Laparotomy
10.7
9.7
18
18
ZXE20
NOMESCO Finland
More than three and less than five hours
3.2
9.6
43
154
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
103.9
9.5
10
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
9.4
9
*
A79
ICPC
Malignancy NOS
+∞
9.4
9
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
9.4
9
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
9.4
9
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
9.4
9
*
WZC00
NOMESCO Finland
Treatment plan or consultation
2.4
9.4
92
491
HAB40
NOMESCO Finland
Wedge excision of mammary gland
38.2
9.1
11
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.6
9.1
22
51
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
19.5
9.0
13
7
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
9.0
106
612
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
28.7
8.6
11
*
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
93.1
8.5
9
*
8441/3-C56.9
ICD-O-3
Serous carcinoma, NOS, of ovary
+∞
8.4
8
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
8.4
8
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
8.4
8
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
8.4
8
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
8.3
61
284
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
8.1
41
157
R2110
NOMESCO Finland
Giving the first information
3.4
8.0
30
96
JN4CD
NOMESCO Finland
Very extensive body CT
13.9
7.5
12
9
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
13.9
7.5
12
9
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.3
7
*
C56.91
ICD-10 Finland
Malignant granulosa cell tumor in ovary
+∞
7.3
7
*
C56.92
ICD-10 Finland
Malignant ovarian tumor, sex chord stroma derived
+∞
7.3
7
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
7.3
7
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
6.0
6.9
18
32
LAE20
NOMESCO Finland
Bilateral oophorectomy
41.2
6.8
8
*
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
3.7
6.7
22
64
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
23.3
6.7
9
*
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
12.7
6.6
11
9
Z3231
NOMESCO Finland
Registered nurse
2.2
6.6
74
409
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
71.6
6.5
7
*
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
18301
ICD-8 Finland
Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary
+∞
6.3
6
*
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
+∞
6.3
6
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.3
6
*
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
+∞
6.3
6
*
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
6.3
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
6.3
6
*
D27.99
ICD-10 Finland
Benign tumor of the ovary (ovary), unspecified histology
27.4
6.3
8
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
6.0
6.3
16
28
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
6.2
118
788
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
13.0
6.1
10
8
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
13.0
6.1
10
8
D39.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ovary
13.0
6.1
10
8
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
93
110
13.02
78.12
2.8
1.5
11.97
2.66
ug/l
1.50
76
81
17
8
22.70
12.19
1.1
1.5
—
—
—
0
0
25
52
5.24
11.71
3.3
1.6
492.75
15.19
u/ml
0.56
20
45
84
475
2.17
7.18
2.4
1.8
—
—
—
0
0
61
306
2.32
6.94
6.6
2.1
0.78
0.82
mmol/l
1.95
56
279
137
948
2.01
6.64
3.1
2.3
—
—
estimate
—
0
0
44
203
2.42
5.99
8.9
5.5
0.79
1.72
mmol/l
0.88
37
175
129
934
1.81
4.90
5.0
3.5
34.93
36.41
g/l
1.96
123
867
8
7
11.76
4.82
3.0
2.1
0.63
1.00
index
—
8
7
195
2174
0.50
4.35
4.7
5.3
5.90
5.86
mmol/l
0.16
173
2003
219
2339
0.40
4.16
31.2
20.0
4.31
4.43
e12/l
3.26
212
2278
25
109
2.44
3.83
12.0
6.3
25.13
25.79
mmol/l
0.33
25
109
127
962
1.66
3.76
7.1
4.8
1.21
1.22
mmol/l
1.44
114
875
70
1007
0.57
3.75
1.9
1.9
1.59
1.31
mmol/l
1.84
64
855
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
37
3.65
3.46
2.7
3.0
0.30
0.49
iu/ml
—
6
26
47
276
1.87
3.39
2.6
1.6
28.54
29.07
s
0.31
47
269
195
2147
0.55
3.26
6.9
6.2
1.87
1.86
mu/l
0.01
175
1999
204
2213
0.53
3.10
4.9
6.1
2.82
2.78
mmol/l
0.24
186
2056
142
1148
1.56
2.94
15.2
6.1
3.99
4.19
e9/l
0.48
115
986
9
22
4.21
2.91
1.2
1.2
—
—
—
0
0
136
1091
1.55
2.90
7.9
5.3
1.20
1.22
mmol/l
2.59
113
948
7
13
5.51
2.89
1.0
1.0
—
—
—
0
0
39
228
1.85
2.85
1.5
1.8
—
—
—
0
0
40
236
1.83
2.84
9.4
5.0
104.53
104.13
mmol/l
0.19
40
236
40
236
1.83
2.84
1.5
1.8
—
—
—
0
0
190
2092
0.59
2.79
5.9
6.6
39.43
39.09
mmol/mol
0.22
173
1963
201
2181
0.56
2.78
4.4
5.4
4.86
4.82
mmol/l
0.21
187
2030
50
318
1.72
2.76
1.7
1.8
—
—
—
0
0
133
1069
1.53
2.76
8.2
3.3
9.49
10.31
umol/l
0.83
126
1011
200
2172
0.57
2.75
4.3
5.3
1.55
1.60
mmol/l
0.85
182
2013
10
30
3.43
2.63
1.2
1.2
—
—
—
0
0
150
1245
1.53
2.63
6.3
3.9
6.64
6.53
mmol/l
0.30
140
1154
9
25
3.70
2.60
1.4
1.2
—
—
—
0
0
11
36
3.15
2.60
1.2
1.1
—
—
—
0
0
22
111
2.08
2.44
12.4
7.1
0.53
0.66
%
0.81
22
111
22
112
2.06
2.39
12.1
7.1
1.16
1.34
%
0.54
22
112
5
8
6.35
2.38
1.2
1.3
—
—
—
0
0
5
8
6.35
2.38
1.2
1.3
—
—
—
0
0
9
29
3.18
2.25
1.2
1.1
—
—
—
0
0
5
9
5.64
2.22
1.2
1.2
—
—
—
0
0
7
22
3.24
1.89
1.7
1.2
—
—
—
0
0
11
46
2.46
1.88
2.8
2.7
—
—
—
0
0
196
2104
0.66
1.77
20.5
12.4
81.71
79.28
ml/min/173m2
0.86
174
1921
7
24
2.97
1.73
1.9
1.2
—
—
—
0
0
49
349
1.51
1.70
3.9
2.8
1.09
1.33
e6/l
0.28
26
166
92
1115
0.72
1.69
2.2
2.6
75.79
80.19
nmol/l
0.73
79
1000
193
2074
0.67
1.68
3.7
4.4
1.33
1.24
mmol/l
1.14
167
1897
45
316
1.52
1.67
4.3
3.0
3.76
4.05
e6/l
0.07
23
129
217
2275
0.60
1.66
15.4
10.1
22.89
22.83
u/l
0.02
207
2196
28
424
0.62
1.62
1.5
1.6
—
—
—
0
0
6
21
2.90
1.51
1.2
1.2
—
—
—
0
0
10
45
2.27
1.48
1.5
1.2
—
—
—
0
0
5
16
3.17
1.44
1.2
1.3
—
—
—
0
0
180
1635
1.38
1.42
9.2
5.4
78.80
75.91
u/l
0.56
166
1520
5
17
2.98
1.36
1.4
1.5
64.80
67.94
umol/l
—
5
17
95
1118
0.75
1.33
3.0
3.1
99.90
82.49
ug/l
0.71
87
1048
118
1348
0.76
1.33
2.4
3.1
—
—
—
0
0
8
34
2.40
1.30
1.1
1.3
—
—
—
0
0
8
34
2.40
1.30
1.1
1.3
—
—
—
0
0
9
45
2.04
1.24
1.6
1.2
—
—
—
0
0
72
581
1.34
1.24
4.7
3.1
0.25
0.51
e6/l
1.19
55
419
22
142
1.60
1.19
1.6
1.6
—
—
—
0
0
18
111
1.67
1.15
1.4
1.6
—
—
—
0
0
7
30
2.37
1.13
1.6
1.2
—
—
—
0
0
178
1903
0.76
1.06
5.8
5.0
15.05
14.79
pmol/l
0.70
162
1754
92
786
1.27
1.02
4.2
2.0
2.38
2.37
mmol/l
0.29
83
691
12
68
1.80
1.02
2.3
2.2
11681.50
3466.67
u/l
—
6
28
62
503
1.31
1.02
2.1
1.7
1.22
1.08
mg/l
0.28
56
398
6
120
0.49
0.96
1.2
1.5
—
—
—
0
0
58
701
0.77
0.93
1.7
1.7
20.39
21.24
nmol/l
0.18
51
597
8
42
1.93
0.89
1.4
1.3
—
—
—
0
0
82
705
1.25
0.85
3.1
2.1
52.42
58.41
u/l
0.54
73
653
95
1073
0.81
0.83
2.1
2.2
97.42
100.47
pmol/l
0.23
48
504
7
122
0.56
0.80
6.0
3.6
5.14
5.24
kpa
—
7
117
82
710
1.23
0.79
4.5
2.4
29.03
28.19
u/l
0.14
77
668
85
740
1.23
0.78
4.5
3.1
—
—
—
0
0
17
117
1.49
0.74
2.5
2.2
0.96
1.16
%
0.50
17
117
14
205
0.66
0.73
1.8
1.9
—
—
—
0
0
159
1691
0.83
0.68
4.8
4.6
16.74
11.76
mm/h
2.55
148
1560
11
70
1.60
0.66
1.2
1.2
—
—
—
0
0
51
600
0.81
0.64
1.3
1.3
1.27
1.80
u/ml
0.27
18
171
5
29
1.74
0.64
5.2
2.1
103.00
106.76
mmol/l
—
5
29
5
29
1.74
0.64
5.2
2.1
1.21
1.19
mmol/l
—
5
29
6
101
0.58
0.63
5.7
3.5
2.52
1.94
mmol/l
—
6
75
11
71
1.58
0.63
2.5
2.0
3.72
5.06
iu/l
—
6
28
8
49
1.65
0.62
1.4
1.4
—
—
—
0
0
68
775
0.83
0.62
3.9
3.9
8.19
5.61
mg/mmol
0.30
41
437
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
48
561
0.82
0.57
4.3
4.1
1.01
1.02
kg/l
0.47
29
368
11
159
0.68
0.56
1.2
1.4
—
38.27
—
0
12
16
116
1.41
0.56
2.6
2.2
0.61
0.63
%
0.16
16
116
45
528
0.82
0.55
1.3
1.4
97.06
34.19
iu/ml
0.52
13
170
17
226
0.73
0.55
1.9
2.1
—
—
—
0
0
133
1237
1.16
0.54
4.9
4.1
0.00
0.02
estimate
0.68
29
244
9
62
1.47
0.53
1.9
1.5
—
0.30
—
0
8
24
299
0.78
0.50
4.0
5.0
36.79
33.42
%
0.48
14
183
8
116
0.68
0.47
1.3
1.5
—
—
—
0
0
9
131
0.68
0.44
1.0
1.1
—
—
—
0
0
208
2135
0.83
0.43
19.3
12.9
30.19
19.46
mg/l
4.01
184
1692
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
73.40
—
0
18
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
13
98
1.34
0.38
1.4
1.7
—
—
—
0
0
5
37
1.36
0.37
4.2
2.6
16.46
16.39
%
—
5
37
10
133
0.74
0.34
2.0
1.4
—
—
—
0
0
59
534
1.14
0.34
3.2
2.0
320.13
318.45
umol/l
0.04
53
460
6
45
1.34
0.34
1.3
1.6
—
—
—
0
0
10
74
1.37
0.33
1.8
1.6
—
—
—
0
0
20
165
1.23
0.32
3.0
1.8
56.50
71.58
ml/min/173m2
—
6
69
7
55
1.28
0.30
1.1
1.3
—
—
—
0
0
20
168
1.21
0.28
5.3
1.5
65.51
67.86
g/l
1.37
20
157
10
77
1.31
0.26
2.0
1.7
—
—
—
0
0
5
72
0.69
0.26
9.0
1.5
6.96
10.13
g/l
—
5
66
37
410
0.89
0.24
4.5
4.2
107.97
228.64
ng/l
0.32
31
308
6
82
0.73
0.24
7.8
1.4
4.02
4.52
g/l
—
6
76
6
82
0.73
0.24
7.8
1.4
3.12
3.70
g/l
—
6
76
6
82
0.73
0.24
7.8
1.4
8.20
7.65
g/l
—
6
76
7
92
0.75
0.23
1.1
1.3
—
20.53
—
0
7
128
1231
1.08
0.22
4.9
4.1
0.00
0.00
estimate
-0.00
29
253
7
95
0.73
0.22
1.4
1.7
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
12.22
—
0
5
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
22
193
1.15
0.20
1.2
1.2
173.07
135.04
u/ml
—
9
80
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
1.07
—
0
7
37
404
0.90
0.19
1.8
1.7
1104.58
1170.08
nmol/l
0.12
19
303
69
651
1.08
0.19
4.4
3.5
0.11
0.00
estimate
0.48
19
197
7
61
1.15
0.17
1.1
1.2
—
—
—
0
0
5
68
0.73
0.17
1.0
1.6
—
—
—
0
0
5
68
0.73
0.17
4.0
2.9
23.08
24.71
mmol/l
—
5
68
14
120
1.18
0.16
1.4
1.8
—
—
—
0
0
125
1217
1.06
0.13
5.0
4.0
0.00
0.00
estimate
-0.00
27
240
22
200
1.11
0.13
4.9
3.3
—
—
—
0
0
17
188
0.90
0.11
1.5
1.5
—
—
—
0
0
54
516
1.06
0.11
1.4
1.5
—
—
—
0
0
5
45
1.11
0.10
5.0
2.1
9.40
6.07
pmol/l
—
5
45
46
479
0.95
0.08
1.5
1.7
452.79
15306577.82
pmol/l
0.50
38
392
8
90
0.89
0.07
1.0
1.4
—
—
—
0
0
50
484
1.04
0.06
1.2
1.3
3.21
10.62
u/ml
1.56
20
190
84
857
0.97
0.05
3.9
3.6
18.53
137.46
ng/l
0.85
57
579
64
654
0.97
0.04
3.4
3.0
1259.36
976.74
ng/l
0.30
55
543
66
671
0.98
0.03
4.7
4.1
0.00
0.00
estimate
-0.00
25
232
143
1437
0.99
0.01
3.6
3.0
44.58
36.76
u/l
0.67
127
1346
22
226
0.97
0.00
2.3
2.0
3.08
3.28
ratio
0.40
17
185
92
919
1.00
0.00
4.7
3.9
0.11
0.04
estimate
0.25
19
190
26
263
0.99
0.00
7.0
6.1
—
—
—
0
0
18
175
1.03
0.00
1.6
1.8
3.39
3.47
mmol/l
0.12
13
133
48
478
1.01
0.00
3.1
2.0
2.49
2.45
mmol/l
1.59
43
426
6
69
0.87
-0.00
1.0
1.1
—
9.98
—
0
9
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
1.20
—
0
5
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
79
0.88
-0.00
1.9
2.5
38.00
41.79
u/l
—
7
68
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
109.22
—
0
9
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
107.80
—
0
5
6
60
1.00
-0.00
1.7
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
216.06
—
0
7
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
-0.00
0.0
3.2
—
106.17
—
0
6
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_OVARY_MUCINO_WIDE – Mucinous and mucinous cystic tumor, including Hilmo
GWS hits: 2
This endpoint is excluded (different definition than used in FinnGen).